| Financial Year |
March 31 2023 |
| Monetary Funds |
411,525,136.90 |
| Held-for-trading Financial Assets |
387,883,491.35 |
| Notes Receivable |
400,000.00 |
| Accounts Receivable |
12,669,525.30 |
| Advances to Suppliers |
5,764,479.62 |
| Other Receivables |
4,512,670.54 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,691,063.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,757,797.71 |
| Total Current Assets |
834,204,165.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
27,860,503.40 |
| Investment Properties |
-- |
| Fixed Assetes |
64,294,610.86 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
110,987.41 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
308,179.73 |
| Deferred Income Tax Assets |
785,872.16 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
118,006,850.22 |
| Total Assets |
952,211,015.54 |
| Short-Term Loans |
10,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
29,027,666.45 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,891,386.77 |
| Taxes Payable |
9,283,394.32 |
| Interest Payable |
-- |
| Dividend Payable |
293,110.45 |
| Other payables |
11,590,712.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,681,071.14 |
| Other Current Liabilities |
913,313.01 |
| Sub-Total of Current Liabilities |
190,622,974.75 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
57,704,282.75 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
59,752,249.67 |
| Total Liabilities |
250,375,224.42 |
| Paid-In Capital(Or Share Stock) |
203,204,897.00 |
| Capital Surplus |
2,311,584,142.64 |
| Surplus Reserve |
32,751,136.24 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,972,637,447.80 |
| Minority Stockholder's Interest |
121,917,008.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
579,918,782.76 |
| Owner's Equity（Stockholder's Equity） |
701,835,791.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
952,211,015.54 |
